Regulatory milestones include EMA approval in 2024 and FDA approval in 2025 for chronic hand eczema, addressing limitations ...

As Dr Wang explains, the combination of robust efficacy, manageable toxicity, and longer follow-up—along with pooled data ...

The oral Janus kinase inhibitor upadacitinib was well tolerated for moderate to severe inflammatory bowel disease over a ...

Dr Bazhenova presents TRUST data at AACR 2026, showing taletrectinib reached a 46.1-month PFS and 89.8% ORR in TKI-naive, ...

Key Takeaways A hormone therapy offered to IVF patients doesn’t work, a new evidence review saysThe treatment involves ...

MIT software boosts SSD speeds by shifting data between drives in large storage clusters, but it's only for use in data ...

Adolescent food insecurity is significantly linked to increased risks for depression, concussion, and inadequate sleep, ...

(Mladen Zivkovic/iStock/Getty Images) A lack of good quality sleep has long been linked to an increased risk of developing ...

Severe stroke survivors face 5x higher dementia risk, while even minor strokes double the odds of cognitive decline.

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been accepted for poster ...

The experimental drug fenebrutinib worked better than Aubagio, an approved therapy, for reducing relapse rates in MS, new ...

As OPM ramps up modernization efforts with a much smaller workforce, the agency's 2027 budget justification reveals where it may be heading the next few years.